BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BAHM - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BAHM
X-ORIGINAL-URL:https://bahm-alliance.org
X-WR-CALDESC:Events for BAHM
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20210314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20211107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20220313T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20221106T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220216T120000
DTEND;TZID=America/New_York:20220216T130000
DTSTAMP:20220225T050835Z
CREATED:20220225T050835Z
LAST-MODIFIED:20220225T050835Z
UID:6908-1645012800-1645016400@bahm-alliance.org
SUMMARY:An Action Plan for Reducing Opioid Overdose Deaths
DESCRIPTION:A Conversation with Ricky Bluthenthal\, PhD\, Keith Humphreys\, PhD\, and Regina LaBelle\, JD\, moderated by Shoshana Aronowitz\, PhD\, MSHP
URL:https://bahm-alliance.org/event/an-action-plan-for-reducing-opioid-overdose-deaths/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220216T120000
DTEND;TZID=America/New_York:20220216T130000
DTSTAMP:20220225T051021Z
CREATED:20220225T051021Z
LAST-MODIFIED:20220225T051021Z
UID:6910-1645012800-1645016400@bahm-alliance.org
SUMMARY:Emerging Scholars Exchange Program: Geoffrey Hoffman\, PhD\, MPH
DESCRIPTION:“Implications of Medicare Policy for Older Adult Functioning and Care”\nOpen to Penn affiliates only
URL:https://bahm-alliance.org/event/emerging-scholars-exchange-program-geoffrey-hoffman-phd-mph/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220216T150000
DTEND;TZID=UTC:20220216T160000
DTSTAMP:20220213T172945Z
CREATED:20220213T172843Z
LAST-MODIFIED:20220213T172945Z
UID:6867-1645023600-1645027200@bahm-alliance.org
SUMMARY:Future of Health: Leading ESG Transformation in Healthcare
DESCRIPTION:In In partnership with the HBS Healthcare Association of San Diego\, The Virtual Roundtable Series will leverage Harvard Business School insights and ideas to address regional challenges and bring together experts from across the Harvard ecosystem to facilitate discussion\, debate\, and discover ways to help solve the key challenges facing the Biopharmaceutical\, Life Sciences\, and government most pressing challenges. \nIn this session\, we will speak on the risks\, benefits\, and challenges ahead on leading the ESG (Environmental\, Social\, and Governance) global transformation within health industries worldwide. \nSpeakers \nMatamba Austin\, Principal\, Advisory\, ESG Partner\, Pricewaterhouse Coopers\nClaudia von Hammerstein\, Partner\, ESG Advisory\, McKinsey\, and Company\nOur Moderator\, Anita Gupta\, GMP 29\, CEO\, Strata Group\, Inc.\, John’s Hopkins School of Medicine \nDate/Time\nWed\, Feb 16th\, 2022\n3pm ET/12pm PT \nBiographies \nMatamba Austin is an ESG partner that helps clients achieve their ESG goals through partnerships\, acquisitions\, and internal transformations. Matamba has deep experience helping private equity firms\, healthcare\, life sciences\, and technology-enabled services organizations through the goal setting\, strategy development\, and execution phases of their initiatives. Matamba’s passion for this work stems from the fact that he owes his existence to ESG initiatives. He is a first-generation American of Caribbean and African heritage. Both of his parents come from underprivileged backgrounds and were able to emigrate to the USA and start a family thanks to their fortuitous access to US-funded and administered ESG programs. Matamba has helped clients with their decarbonization\, DEI\, health equity and ESG governance initiatives. Matamba has a BA from Harvard College and JD from Harvard Law School. \nClaudia von Hammerstein’s work focuses on improving global health through health technology innovation and sustainability. She works with pharmaceutical\, medical products\, and digital health companies typically on strategic\, digital\, and organizational issues. She co-leads our global medical affairs work and has developed innovative approaches such as analytics for unmet medical needs and medical launch readiness. Claudia is a leader in our sustainability work in the firm’s Pharmaceuticals & Medical Products Practice across the environmental\, social\, and governance sectors\, and works with innovative health technology companies to push the boundaries in this space. \nDr. Anita Gupta is Chief Executive Officer of the Strata Group\, Inc.\, a leading global healthcare business firm specializing in strategy\, policy\, and innovation. She serves as a Board of Director of HealthyWomen and Board Advisor of Bionaut\, Inc. Dr. Gupta served on the Board of Directors of Amorsa Therapeutics\, Inc\, a biopharmaceutical neuroscience company\, aligning a strategic collaboration facilitated by Johnson & Johnson. Dr. Gupta has held the positions of Senior Vice President\, Medical Strategy and Government Affairs at Heron Therapeutics\, Inc\, a publicly traded biopharmaceutical company focused on oncology and pain therapeutics\, and Vice-Chair of Tenet Healthcare at Drexel University School of Medicine. She serves as an HBS Ambassador\, FDA advisor\, Department of Defense advisor\, and appointed member of the National Academies of Sciences\, Engineering and Medicine Global Forum and a Distinguished Fellow of the National Academies of Practice. Dr. Gupta serves as appointed faculty at the Johns Hopkins School of Medicine\, Anesthesiology and Critical Care. Dr. Gupta holds an M.P.P. and H.H.P. from Princeton University\, GMP in Business Management from Harvard Business School\, B.S and Pharm.D. in Pharmacy\, from Rutgers University\, and a D.O. from the University of Medicine and Dentistry of New Jersey. Dr. Gupta is board-certified in anesthesiology and pain medicine and is a fellow of the American Society of Anesthesiologists and named a Goldman Sachs 10K Small Business Scholar\, Top 100 Inspiring Leader by PharmaVoice\, Top 10 Emerging Leader by Pharmaceutical Executives\, and Top 10 Women of Influence by Fierce Healthcare.
URL:https://bahm-alliance.org/event/6867/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20220226T100000
DTEND;TZID=America/Halifax:20220226T112000
DTSTAMP:20220226T222903Z
CREATED:20220226T222903Z
LAST-MODIFIED:20220226T222903Z
UID:6918-1645869600-1645874400@bahm-alliance.org
SUMMARY:HEALTH ECONOMICS WORKSHOP (SEMINAR SERIES)
DESCRIPTION:Tim Layton (Harvard) \nThe Health Economics Workshop for Fall 2021 and Spring 2022 will be held in person on Fridays from 10:00 – 11:20 a.m. (Eastern Time) unless otherwise specified. The workshop is hosted by Wharton Health Care Management.
URL:https://bahm-alliance.org/event/health-economics-workshop-seminar-series-2/
END:VEVENT
END:VCALENDAR